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Port-a-caths in cancer patients
CLIVE L. SINOFF, TERRY KOSKI
Abstract We report on 91 patients with cancer who under-
went the insertion of 89 venous and 4 hepatic arte-
rial, implanted vascular ports (port-a-caths) for
periods of up to 33 Illonths (total 1 525 patient-
ITlOnths). There were 1 fatal, 9 serious and 8 Illinor
cOlnplications in 18 patients which are described
and discussed. In this series, cOIllplications were
more common in younger patients, and infection
was rare.
Port-a-caths are extremely useful for vascular
access, and have a low complication rate. How-
ever, the occasional occurrence of serious and
even fatal complications suggests that the decision
to insert a device should be judiciously weighed.
S Atr Med J 1993; 83: 412-416.
M ost cytostatic agents require reliable venousaccess for administration. This may be difficultto obtain, especially in patients who are elderly
or obese. Central vascular lines circumvent this prob-
lem. The larger lumen also allows the easy administra-
tion of intravenous drugs, blood products or parenteral
nutrition, while blood may also be withdra\'m for analy-
sis. Since the usual plastic indwelling catheters used for
acute problems are not durable, Silastic catheters are
commonly insened for longer term use (Broviac and
Hickman lines); these protrude through the skin and the
loose external ends are capped when not in use.
More recently, long-indwelling right atrial Silastic
catheters have been attached to an implanted subcuta-
neous stainless steel or titanium pon which can be fre-
quently accessed percutaneously through a self-sealing
silicone plug (Pon-a-cath and others). We have been
using Pon-a-caths since January 1984 in patients with
poor vascular access. Fatal septicaemia related to infec-
tion of the Port-a-cath runnel in one patient and other
serious complications in other patients prompted us to
review the results in our own patients. This repon of our
experience \vith subclavian venous and hepatic anerial
Pon-a-caths in a community hospital and oncology pro-
gramme illustrates the benefits and risks in patients with
solid tumours.
Material and methods
We retrospectively reviewed the chans of 91 cancer
patients over the age of 16 registered with the North-
eastern Ontario Regional Cancer Centre who under-
went the insertion of an implanted pon and vascular line
between 1 January 1984 and 1 January 1990 to assess
the complications of the insertion and use of this device.
Patients ranged in age from 18 to 76 (median 58 years,
mean 53 years). Patients with acute leukaemia, with
percutaneous catheters without pons and those with
catheters insened at other institutions were excluded
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from analysis. Most of our patients received a subclavian
venous Pon-a-cath (Pharmacia (Canada) Inc.) and this
repon deals predominantly with these devices. The
unassembled venous Port-a-caths used in these patients
had the follmving specifications: titanium pon, 25,4 mm
base, 13,5 mm height, septum 11,4 mm in diameter;
weight 16 g; catheter external diameter 2,8 mm and
internal diameter 1,0 mm. Specifications are slightly dif-
ferent for anerial catheters and may have changed for
newer models.
Indications for a central venous line were variable,
largely because of the subjective difficulty of experienced
oncology nurses in finding veins for the administration
of cytostatic therapy. Two patients received central
venous lines for parenteral nutrition, 2 for prolonged
pain control by intravenous morphine infusion and 1 for
rehydration. All central venous lines were placed by per-
cutaneous puncture into a subclavian vein under local
anaesthesia, usually on an outpatient basis, so that the
distal end lay at the junction of the superior vena cava
and right atrium, or slightly within the right atrial cavity.
Hepatic arterial Pon-a-caths were surgically insened
under general anaesthesia for chemotherapy in 4
patients with hepatic metastases. Most (83 of 93) were
inserted by only two surgeons using standard tech-
niques. I •2 A detailed description of the techniques is
available from the manufacturers. Whenever possible,
insertion of an indwelling line was postponed until
recovery from episodes of neutropenia, thrombocyto-
penia or active infection. A chest radiograph was done
in all cases before and after insertion.
Use of the porrs was begun as early as the same day
as the insertion. Venous pons were flushed with la ml
0,9% saline and heparinised with 6 ml of 100 U/ml
heparin after each use or every 4 weeks when not in
active use. Arterial pons were flushed with 10 ml 0,9%
saline and heparinised with 6 ml of 1 000 U/ml heparin
weekly or after each use. Some patients failed to comply
with regular monthly heparinisation. Special aseptic pre-
cautions were taken throughout. In the case of patients
receiving daily injections, an 18 cm extension tube was
often left in place and capped for reuse the next day.
Only Huber 22-gauge right-angle needles were used for
access, as these do not core out the seprum.'
Various intravenous cytostatics were given intermit-
tently to 41 men and 50 women with cancer (excluding
acute leukaemia). J\il.ost cytostatic therapy was admini-
stered by infusion over 1 - 2 hours. Nine patients
received a continuous intravenous infusion of cyrostatics
for periods of up to 5 days. Pons in sim were also used
as required for antimicrobial agents, blood products or
parenteral nutrition. The hepatic arterial POrtS were
used only for the continuous infusion of fluoro-uracil (3
patients) or adriamycin Cl patient).
Complications were classified as serious (fatal, life-
threatening or resulting in symptomatic problems
requiring hospital admission or an invasive procedure),
or minor (all others, e.g. haematomas not requiring
therapeutic intervention, extravasation without tissue
damage). Patients with more than one complication
were classified according to the most serious one. The
mean ages of those with and without complications were
compared using the standard error of difference
between means.'
The minimum direct costs of insertion and each
access are shown in Canadian dollars according to the
current price and fee schedules in Ontario.
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TABLE I.
Patients with serious Port-a-cath-related complications
Patient Age Sex Complication{s) Outcome
55 M Major pneumothorax; septicaemia Resolved with intercostal drainage; sudden death
(with neutropenia) 5 weeks after insertion considered unrelated
2 59 M Major pneumothorax Resolved with intercostal drainage
3 41 M Major pneumothorax Resolved with intercostal drainage
4 46 M Wound infection; Staphylococcus Patient died with multiple metastatic abscesses
aureus cultured; loop in right
subclavian vein possibly unrelated
5 31 M Infection in wound and tunnel; fever Infection resolved with catheter removal; prior
(preceded by occlusion - minor occlusion relieved with streptokinase
complication)
6 61 M Wound infection and dehiscence; Infection resolved with catheter removal
S. aureus
7 21 M Thrombophlebitis Recovery; catheter removal
8 26 F Catheter fracture and embolisation; Removal transvenously with difficulty
kink seen
9 27 M Catheter fracture and embolisation; Removal transvenously with difficulty
no kink noted
10 20 F Catheter partially retained at removal Required open surgical removal
TABLE 11.
Patients with minor Port-a-cath-related complications
Patient Age Sex Complication(s) Outcome
11 35 F Hepatic artery thrombosis Catheter removed; no deleterious sequelae
(hepatic arterial catheter)
12 33 F Sterile granuloma Catheter removed at patient's request
13 48 F Small pneumothorax; occlusion Resolved; catheter removed
14 72 M Minor haematoma Resolved
15 39 F Kink at first rib Catheter removed and replaced on opposite side
16 49 F Extravasation of fluoro-uracil from No sequelae
hepatic arterial line on two occasions
17 48 M Migration of catheter tip to right In situ - no sequelae
ipsilateral internal jugular vein
18 72 M Large haematoma in chest wall Resolved gradually
(mild bleeding tendency)
Results
Serious complications (1 of which proved fatal)
occurred in 10 patients (11 %) (Table I) and minor
complications in another 8 (9%) (Table 11).
Difficulties in percutaneous insertion were fairly
common and there were 6 occasions where this initially
failed. In each case except one, a Port-a-cath was suc-
cessfully inserted in the contralateral subclavian vein.
Four patients had an immediate pneumothorax and
intercostal drainage was required in 3 of them.
Infection occurred in 3 patients after 3 - 16 months
of use. All 3 had wound infections and one had an
extension to the catheter runnel. In 2 cases, Staphy-
lococcus aureus was cultured from the pus. The infections
settled in 2 of the 3 patients with antibiotics and
catheter removal. The fatal infection occurred in a 46-
year-old man with non-small-cell lung cancer who had a
Port-a-cath inserted without difficulty. He first showed
signs of soft-tissue infection overlying the port 3 months
after insertion, and it was accompanied by fever and
neutropenia. After a brief resolution on antibiotics, the
infection recurred and progressed despite intensive
antibiotic treatment. A chest radiograph showed a com-
plete loop of the catheter in the right subclavian vein
(Fig. 1), bur no obstruction was noted. His cancer pro-
gressed concurrently and he died with an empyema and
loculated pleural abscesses a month after his third
admission. Despite multiple culture specimens, S.
aureus was cultured on only a single occasion from pus
at the port site. The catheter was removed just before
the patient's death.
FIG. 1.
Radiograph of patient 4 showing a complete loop of the
catheter in the right subclavian vein. This patient eventually
died from infection of the port and metastatic abscesses
caused by S. aureus. The loop may be incidental.
•
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FIG. 4.
Migration of the catheter end to the right internal jugular
vein (patient 17).
FIG. 3.
The 'pinch-off' sign at the junction of the first rib and
clavicle (patient 15).
Most patients had venesections done through peri-
pheral veins in order to minimise complications. Our
nurses estimated that difficulty in obtaining blood return
through the Port-a-cath despite easy infusion at the time
of chemotherapy occurs in about 10% of patients (exact
figures unknown).
FIG. 2.
Radiograph of patient 9 showing the fracture site at the
junction of the medial aspect of the first rib and the
clavicle. The embolic distal segment can be seen in the
lower right of the picture.
A 26-year-old woman and a 27-year-old man had
embolisation of the distal catheter segment which frac-
rured in the region of the first rib (Fig. 2), 6 and 13
months respectively after insertion. The distal catheter
segments were removed trallsvenously by cardiologists,
without sequelae. This was, however, a painstakingly
prolonged and difficult procedure in each case. Only
one removed catheter was available for inspection and
this showed an oval segment at the site of rupture due to
extrinsic compression. A small kink (pinch-off sign') was
subsequently nOted in one catheter overlying the first rib
on the plain postero-anterior chest film. Furthermore,
nurses had noted some positional resistance to flow in
this patient. Our experience in the first of 2 patients led
us to remove an intact catheter 3 1/2 months after inser-
tion from a 39-year-old woman showing kinking with
resistance to flow (Fig. 3). The removed catheter
appeared normal on inspection. Another catheter was
successfully placed on the contralateral side. These 3
patients have been described briefly elsewhere.'
One patient developed significant axillary vein
thrombosis which resolved with anticoagulation and
removal of the catheter. Another with a hepatic arterial
line had thrombosis of the artery without sequelae.
Minor complications including transient and super-
ficial wound infection, wound dehiscence, large
haematomas, hepatic artery thrombosis and extravasa-
tion of fluoro-uracil occurred in 8 patients (Table 11).
One patient experienced migration of the distal catheter
up the right internal jugular vein (Fig. 4). Two catheters
became blocked but patency was restored in one using
streptokinase; the other catheter was removed.
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Direct costs in Canadian dollars of insertion and access
of an uncomplicated Port-a-cath
This appears to be due to the valve-like action of a
fibrous sheath developing around the venous portion of
the catheter. Both complete and panial occlusion will
usually be reversed by thrombolytic infusion. As this
may be required on more than one occasion, urokinase
is preferable to streptokinase."·13
Venous thrombosis occurs quite frequently in some
series and this toO usually responds to thrombolytic
agents·2•14 but rarely requires catheter removal.'·'·15 It is
uncenain if regular flushing with heparin, as was done
in our patients, contributes to a lower rate of occlusion
or thrombosis. 15
Extravasation of cyIostatics from Pon-a-caths is an
uncommon problem.1.6.16 The dangers required special
emphasis for those receiving outpatient infusions of
cyrostatics which may cause soft-tissue necrosis.
Another uncommon complication is disruption or
fracture of the catheter at the passage between the first
rib and clavicle!·6 It is interesting that our 2 patients,
aged 26 and 27, in whom this occurred (Fig. 2), and a
third aged 39 in whom kinking of the catheter suggested
the risk of disruption (Fig. 3), were all younger than
most of our patients (mean of the whole group 58 years,
median 53 years) and were all fairly physically active in
the period when dislodgement occurred.
Factors which potentially predispose to complica-
tions include the type of cancer, duration and severity of
neutropenia, the patient's age and performance status,
recent chemotherapy, use soon after insenion, experi-
ence and skill of the surgeon inserting the catheter,
the type and size of the catheter and techniques of
access.';I.lI.17 one are proven. Surprisingly, complica-
tions, especially serious ones, were statistically more
common in younger patients in this series. Possible
explanations include the generally greater physical acti-
vity and mobility of younger patients, or a greater dis-
regard for the presence of the devices. Our data were
insufficient to analyse putative predisposing factors, but
we hope to do this by prospective study. Although
unproven, it seems prudent that, whenever possible,
insertion should be delayed until recovery from neu-
tropenia. Delaying the first use of the pon after insenion
is not clearly advantageous.
The insenion of a Pon-a-cath is an expensive under-
taking. In addition to the direct costs shown in Table
IV, patients with complications will incur additional
expenses for radiographs, bacterial cultures, antibiotics,
surgery, hospitalisation and catheter removal. These
costs are difficult to quantitate and are sometimes indis-























Approximate minimal cost per access'
Some type of complication is reponed in over 30% of
patients with Pon-a-caths; catheter removal is required
in 6 - 30% of cases.2-4.6-15
A pneumothorax, occasionally requiring intercostal
drainage, may result from perforation of the apex of the
lung at the time of insertion but this appears to be
uncommon' and occurred in only 4 of our patients.
Other structures in the supraclavicular fossa including
the subclavian artety, may rarely be damaged, usually
without sequelae.6
Infection after successful insenion is reported as the
most frequent complication, although this was not the
case in our patients. It has been suggested that most
bacteraemias and infections of the exit site can be
treated with antibiotics alone, but that runnel infections
require removal of the catheter. Additionally, infections
due to Bacillus spp. Candida spp., and JK Coryne-
baClerium are considered difficult to eradicate without
catheter removal.6-lI Although the commonest organism
reponed is S. epidennidis, this was not identified in any
of our patients; S. aureus was identified in 2 of 3 patients
with infection. The long delay before evidence of in-
fection (3 months in 2 of our patients, 16 months in
another) suggests that it is more commonly acquired
from circulating bacteria or from non-sterile punctures
rather than at the rime of insenion. Prophylactic vanco-
mycin at the rime of surgery and/or with each access
may be used, where infections with Gram-positive
organisms are relatively common,' but our figures (3
infections in 93 catheters) show that low infection rates
can be achieved without prophylactic antibiotics, and
the value of vancomycin remains unproven. The rarity
of infection in our patients may be due to the exclusion
of patients with acute leukaemia, postponement of
insenion while neutropenic, and the conscientious asep-
tic technique of trained oncology nurses.
Catheter occlusion is reponed in up to 25% of
catheters' but this occurred in only 2 of our patients.
'Persistent withdrawal occlusion' resulting in difficulty
in blood withdrawal despite easy infusion is nor uncom-
mon (occurring but not documented in our patients)."
The means were compared using the 'standard error of the difference between
means'.2
The minimal direct cost of the Pon-a-cath, surgical
fee, theatre time and control radiographs is approxi-
mately Canadian $868,00 (Table IV). The minimum
direct cost for each access is approximately Canadian
$7,20. (Canadian $1,00 =US $0,85 and =R2,14 at the
rime of writing.)
No. of
patients Mean age P-value
Any complications 18 43,5 ± 16,1
With P< 0,002
Without 73 56,3 ± 13,2
Serious complications 10 38,7 ± 15.8
With P< 0,001
Without 81 55.6 ± 13,5
Discussion
TABLE Ill.
Age comparisons of patients with or without any compli-
cations and serious complications
The mean age of those with a complication of any
severity and those with serious complications is com-
pared with those without (Table llI). The mean age of
patients with complications was significantly lower than
that of those \vithout complications.
The selection of an implantable venous pon over
peripheral venous access must necessarily be subjective
and depends on the condition of the patient's veins, the
skill, patience and experience of the therapist insening
peripheral catheters, and the patient's life expectancy
and the strength of the indication. Many patients with
poor veins prefer the certainty of venous access for
therapy and blood sampling, to the anxiety accompany-
ing multiple attempts to access peripheral veins. Despite
the advantages of implanted devices, the cost is signifi-
cant and the complications, though uncommon, may be
serious. Every technique should be used to enhance the
success of peripheral venous cannulation (warming the
limb or hand, obtaining adequate proximal venous com-
pression, etc.), before considering an implanted device.
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The 'econoll1.ics' of ll1.edical technology
G. G. JARos, D. A. BOONZAIER
Abstract The word 'economics' is used in this paper in its
widest sense, referring to issues that 'influence the
management, regulation and government of an
enterprise'. In addition to the obvious monetary
issues in health-care technology, social, ethical,
legal and cultural issues are also discussed. The
eventual, generally high cost of health care is defi-
nitely influenced to a greater or lesser extent by
these factors. It is suggested that proper evalua-
tion during the planning stage could lead to the
development and introduction of technologies into
health care in a more cost-effective way.
S Air Med J 1993; 83: 416-419.
O
ne of the greatest technological achievements of
mankind was the marriage of the horse and cart
for transport purposes. This marvellous combi-
nation of energy source and low-friction vehicle made it
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possible for man to open up the interior of continents
for travel and commerce. The example of the wheeled
horse-cart with a good driver highlights the importance
of choosing the righr combination of technology and
techniques to allow available resources to be usefully
directed.
In the last 100 years or so there has been an abiding
hope that the increasing application of technology to
problem areas could likewise conquer disease. Is this
hope being realised or is there something amiss? There
are dark rumblings about the side-effeCts and dangers of
rechnology; an increasingly anti-science culture pro-
poses a 'back to the earth' philosophy. The concept of
'health-care technology' is provoking more and more
ambivalence. If we do not address these concerns as a
matter of urgency, there is a real danger that the whole
health-care cart will come crashing down, patienrs and
all.
The word 'economics' is used in this paper in its
widest sense, viz. 'the management, regulation and
governmenr of a household'. As such it does not refer
simply to monetary considerations, but in the conrext of
health care, to the much broader societal implications.
Health is probably the most valuable of all human
attributes, yet we often take it for granted and place it at
risk. Paradoxically, once we have lost it we are prepared
to do anything ar any price to regain it. Cosrs seem to
